Abstract
Primary central nervous system (cerebral) lymphoma is an intracranial neoplasm with an increasing incidence in the last 15 years, perhaps tripling in the last 10 years [1,2]. These tumors are infiltrative, multifocal tumors with a predilection for the paraventricular brain areas. Treatment of intracerebral lymphoma has followed the standard parameters of intracranial neoplasia, including steroids and radiation therapy. Treatment with steroids transiently reduces cerebral edema and may even be lympholytic in this tumor [3–5]. Therapy is problematic because the duration of the response to steroids and/or radiation therapy has been short, resulting in a median survival of approximately 14 months.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams JH, Howatson AG: Cerebral lymphomas: review of 70 cases. J Clin Pathol 43: 544–547, 1990.
Eby NL, Grufferman S, Flannelly CM, et al.: Increasing incidence of primary brain lymphoma in the U.S. Cancer 62:2461–2465, 1988.
Baxter J, Harris A, Tomkins G, et al.: Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science 171:189–191, 1970.
Gametchu B: Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis. Science 236:236–237, 1987.
Pohl P, Oberhuber G, Dietze O, et al.: Steroid-induced complete remission in a case of primary cerebral non-Hodgkin’s lymphoma. Clin Neurol Neurosurg 91:247–250, 1989.
Weingarten K, Zimmerman R, Leeds N: Spontaneous regression of intracerebral lymphoma. Radiology 149:721–724, 1983.
Dorreen MS, Ironside JW, Bradshaw JD, et al.: Primary intracerebral lymphoma: a clinicopathological analysis of 14 patients presenting over a 10 year period in Sheffield. Q J Med 67:387–404, 1988.
Neuwelt EA, Frenkel EP, Gumerlock MK, et al.: Developments in the diagnosis and treatment of primary CNS lymphoma: a prospective series. Cancer 58:1609–1620, 1986.
Pollack IF, Lunsford LD, Flickinger JC, et al.: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63:939–947, 1989.
Bessell M, Punt J, Firth J, et al.: Primary non-Hodgkin’s lymphoma of the central nervous system: phase II study of chemotherapy prior to radiotherapy. Clinical Oncol 3:193–198, 1991.
Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68:835–853, 1988.
O’Neill BP, Illig JJ: Primary central nervous system lymphoma. Mayo Clin Proc 64: 1005–1020, 1989.
Bonnin JM, Garcia JH: Primary malignant non-Hodgkin’s lymphoma of the central nervous system. Pathol Annu 22:353–375, 1987.
Burstein SD, Kernohan JW, Uihlein A: Neoplasms of the reticuloendothelial system of the brain. Cancer 16:289–305, 1963.
Kiya K, Uozumi T, Kurisu K, et al.: Outcome of primary central nervous system lymphoma. Neurol Med Chir (Tokyo) 31:194–198, 1991.
Correale JD, Monteverde DA, Bueri JA, et al.: Craniocerebral involvement in lymphoma. Arq Neuropsiquiatr 48:306–314, 1990.
Correale J, Monteverde DA, Bueri JA, et al.: Peripheral nervous system and spinal cord involvement in lymphoma. Acta Neurol Scand 83:45–51, 1991.
Recht LD: Neurologic complications of systemic lymphoma. Neurol Clin 9:1001–1015, 1991.
Remick S, Diamond C, Migliozzi J, et al.: Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome: a retrospective analysis and review of the literature. Medicine 69:345–360, 1990.
Woolf AS, Conway G: Systemic lupus erythematosus and primary cerebral lymphoma. Postgrad Med J 63:569–571, 1987.
Bashir RM, Harris NL, Hochberg FH, et al.: Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization. Neurology 39:813–817, 1989.
DeAngelis L: Primary central nervous system lymphoma as a secondary malignancy. Cancer 67:1431–1435, 1991.
Van Bolden V, Kline DG, Garcia CA, et al.: Isolated radial nerve palsy due to metastasis from a primary malignant lymphoma of the brain. Neurosurgery 21:905–909, 1987.
Pauzner R, Mouallem M, Sadeh M, et al.: High incidence of primary cerebral lymphoma in tumor-induced central neurogenic hyperventilation. Arch Neurol 46:510–512, 1989.
Kuwabara Y, Ichiya Y, Otsuka M, et al.: High [18F] FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr 13:47–48, 1988.
Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of literature. J Neurosurg 65:600–607, 1986.
DeAngelis L, Yahalom J, Thaler H, et al.: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635–643, 1992.
Benjamin I, Case M: Primary reticulum cell sarcoma (microglioma) of the brain with massive cardiac metastases. J Neurosurg 53:714–716, 1980.
Hochberg RH, Miller G, Schooley RT, et al.: Central nervous system lymphoma related to Epstein-Barr virus. N Engl J Med 30:745–748, 1983.
List AF, Greer JP, Cousar JP, et al.: Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus. Mod Pathol 3:609–612, 1990.
Thomas M, MacPherson P: Computed tomography of intracranial lymphoma. Clin Radiol 33:331–336, 1982.
Jack CR, Reese DF, Scheithauer BW: Radiographic findings in 32 cases of primary CNS lymphoma. AJR 146:271–276, 1986.
Jack CR, O’Neill BP, Banks PM, et al.: Central nervous system lymphoma: histologic types and CT appearance. Radiology 167:211–215, 1988.
Ohkawa A, Yamadori A, Mori E, et al.: A case of primary malignant lymphoma of the brain with high uptake of 123I-IMP. Neuroradiology 31:270–272, 1989.
Hochberg FH, Loeffler JS, Prados M: The therapy of primary brain lymphoma. J Neurooncol 10:191–201, 1991.
Helle TL, Britt RH, Colby TV: Primary lymphoma of the central nervous system. J Neurosurg 60:94–103, 1984.
Neuwelt EA, Gumerlock MK, Dahlborg SA: Primary central nervous system lymphomas. In JR Youmans, ed. Neurological Surgery, 3rd ed. Philadelphia: WB Saunders, 1989, pp 3137–3151.
Oberg G, Hallgren R, Venge P: Beta2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate. Br J Hematol 66: 315–322, 1987.
Spaun E, Midholm S, Pedersen NT, et al.: Primary malignant lymphoma of the central nervous system. Surg Neurol 24:646–50, 1985.
Bogdahn U, Bogdahn S, Mertens HG, et al.: Primary non-Hodgkin’s lymphomas of the CNS. Acta Neurol Scand 73:602–614, 1986.
O’Neill BP, Kelly PJ, Earle JD, et al.: Computer-assisted stereotactic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology 37:1160–1164, 1987.
Namiki TS, Nichols P, Young T, et al.: Stereotactic biopsy diagnosis of central nervous system lymphoma. Am J Clin Pathol 90:40–45, 1988.
Simon J, Jones EL, Trumper MM, et al.: Malignant lymphomas involving the central nervous system—a morphological and immunohistochemical study of 32 cases. Histo-pathology 11:335–349, 1987.
Pappas CT, Johnson PC, Sonntag VK: Signet-ring cell lymphoma of the central nervous system. J Neurosurg 69:789–792, 1988.
Geppert M, Ostertag CB, Seitz G, et al.: Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol 80:629–634, 1990.
Singh A, Strobos RJ, Singh BM, et al.: Steroid-induced remissions in CNS lymphoma. Neurology 32:1267–1271, 1982.
Sugita Y, Shigemori M, Yuge T, et al.: Spontaneous regression of primary malignant intracranial lymphoma. Surg Neurol 30:148–152, 1988.
Vaquero C, Martinez R, Rossi E, et al.: Primary cerebral lymphoma: the ‘ghost tumor.’ J Neurosurg 60:174–176, 1984.
Williams RS, Crowell RM, Fisher CM, et al.: Clinical and radiologic remission in reticulum cell sarcoma of the brain. Arch Neurol 36:206–21, 1979.
Taylor CR, Russell R, Lukes RJ, et al.: An immunohistological study of immunoglobulin content of primary central nervous system lymphomas. Cancer 41:2197–2205, 1978.
Kanavaros P, Mikol J, Nemeth J, et al.: Stereotactic biopsy diagnosis of primary non-Hodgkin’s lymphoma of the central nervous system: a histological and immunohistochemical study. Pathol Res Pract 186:459–466, 1990.
Hardwidge C, Diengdoh JV, Husband D, et al.: Primary cerebral lymphoma—a clinical-pathologic study. Clin Neurol Pathol 9:217–223, 1990.
Morgello S, Maiese K, Petito CK: T-cell lymphoma in the CNS: clinical and pathologic features. Neurology 39:1190–1196, 1989.
Smith WJ, Garson JA, Bourne SP, et al.: Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate a mature phenotype. J Clin Pathol 41:128–132, 1988.
Bashir RM, Harris N, Blain K, et al. Hochberg F: Immunophenotypic profile of CNS lymphoma: a review of eighteen cases. J Neurooncol 7:249–254, 1989.
Efremidis AP, Sabato U, Taff I, et al.: Diagnosis of CNS lymphoma using immunofluores-cent phenotyping of CSF mononuclear cells. Clin Neurol Neurosurg 88:101–107, 1986.
Di Marco A, Rosta L, Campostrini F, et al.: The role of radiation therapy in the management of primary non-Hodgkin lymphomas of the central nervous system. Tumori 72: 565–573, 1986.
Grote TH, Grosh WW, List AF, et al. Johnson DH: Primary lymphoma of the central nervous system: a report of 20 cases and a review of the literature. Am J Clin Oncol 12:93–100, 1989.
Loeffler JS, Ervin TJ, Mauch P, et al.: Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3:490–494, 1985.
Shibamoto Y, Tsutsui K, Dodo Y, et al.: Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65:1907–1912, 1990.
Michalski JM, Garcia DM, Kase E: Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology 176:855–860, 1990.
Margolis L, Fraser R, Lichter A, et al.: The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 45:688–692, 1980.
Merchut MP, Haberland C, Naheedy MH, et al.: Long survival of primary cerebral lymphoma with progressive radiation necrosis. Neurology 35:552–556, 1985.
Crossen Jr, Goldman DL, Dahlborg SA, et al.: Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery 30:23–29, 1992.
Neuwelt EA, Dahlborg SA, Goldman D, et al.: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9:1580–1590, 1991.
Abelson HT, Dufe DW, Skarin AT, et al.: Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep 65:137–140, 1981.
Cohen IJ, Vogel R, Matz S, et al.: Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol. Cancer 57:6–11, 1986.
Gabbai AA, Hochberg FH, Linggood R: High dose methotrexate therapy of primary brain lymphoma. J Neurosurg 70:190–194, 1989.
McLaughlin P, Velasquez WS, Redman JR, et al.: Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma. J Natl Cancer Inst 80:1408–1412, 1988.
Pitman SW, Frei E: Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization of nephrotoxicity: pharmacokinetics in the CNS and the use in CNS non-Hodgkin’s lymphoma. Cancer Treat Rep 61:695–701, 1977.
Ott RJ, Brada M, Flower MA, et al.: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27:1356–1361, 1991.
Gumerlock MK, Belshe BD, Madsen R, et al.: Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review. J Neurooncol 12:33–46, 1992.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gumerlock, M.K., Neuwelt, E.A. (1993). Primary cerebral lymphoma. In: Dana, B.W. (eds) Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems. Cancer Treatment and Research, vol 66. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3084-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3084-8_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6347-7
Online ISBN: 978-1-4615-3084-8
eBook Packages: Springer Book Archive